ASH 2013: Abstract 2077 - Dr. Marco Ladetto

Marco Ladetto, MD Division of Hematology Department of Molecular Biotechnologies and Health Sciences University of Torino Torino, Italy Abstract 2077 - Long-term molecular results of the GIMEMA VEL-03-096 trial: molecular remission achievement and loss are major outcome predictors Visit our website at: http://www.myeloma.org Find us online: Facebook: http://facebook.com/myeloma Google+: http://gplus.to/imfmyeloma IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma) Dr. Durie on twitter: @BrianDurieMD (http://twitter.com/brianduriemd) Support the IMF! http://bit.ly/WskQHC Category Nonprofits & Activism License Standard YouTube License: